https://ir.neximmune.com/ 2026-05-27T10:22:49Z https://ir.neximmune.com/events/event-details/2021-cantor-virtual-global-healthcare-conference 2026-05-27T10:22:53Z https://ir.neximmune.com/events/event-details/38th-annual-society-immunotherapy-cancer-meeting 2026-05-27T10:22:52Z https://ir.neximmune.com/events/event-details/american-society-transplantation-and-cellular-therapy 2026-05-27T10:22:52Z https://ir.neximmune.com/events/event-details/asco-presentation 2026-05-27T10:22:53Z https://ir.neximmune.com/events/event-details/barclays-2022-global-healthcare-conference 2026-05-27T10:22:53Z https://ir.neximmune.com/events/event-details/hc-wainwright-24th-annual-global-investment-conference 2026-05-27T10:22:52Z https://ir.neximmune.com/events/event-details/leukemia-lymphoma-society-therapy-acceleration-programr-lls-tap-panel 2026-05-27T10:22:53Z https://ir.neximmune.com/events/event-details/morgan-stanley-19th-annual-global-healthcare-conference 2026-05-27T10:22:53Z https://ir.neximmune.com/events/event-details/raymond-james-2021-human-health-innovation-conference 2026-05-27T10:22:52Z https://ir.neximmune.com/investors/contact 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/corporate-governance 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/email-alerts 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/events-and-presentations 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/financial-and-filings 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/overview 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/aim-technology-investor-guide 2026-05-27T12:00:00Z https://ir.neximmune.com/investors/press-releases 2026-05-27T10:22:49Z https://ir.neximmune.com/investors/stock-information 2026-05-27T10:22:49Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-1-25-reverse-stock-split 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-367-million-registered-direct-offering 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-closing-367-million-registered-direct 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-poster-presentation-2023-focis-annual 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-presentations-society-immunotherapy-cancers 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-announces-workforce-reduction-enable-continued-aimtm 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-presents-initial-positive-data-nexi-001-phase-1-trial 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-first-quarter-2021-financial-results-and 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-first-quarter-2022-financial-results-and 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-first-quarter-2023-financial-results-and 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-fiscal-year-2020-financial-results-and-recent 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-fourth-quarter-and-full-year-2021-financial 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-fourth-quarter-and-full-year-2022-financial 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-second-quarter-2021-financial-results-and 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-second-quarter-2022-financial-results-and 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-second-quarter-2023-financial-results-and 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-third-quarter-2021-financial-results-and 2026-05-27T10:22:52Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-reports-third-quarter-2022-financial-results-and 2026-05-27T10:22:51Z https://ir.neximmune.com/news-releases/news-release-details/neximmune-yale-and-jdrf-extend-research-partnership-type-1 2026-05-27T10:22:52Z https://ir.neximmune.com/sec-filings/sec-filing/10-k/0001193125-21-102236 2026-05-27T10:22:51Z https://ir.neximmune.com/sec-filings/sec-filing/10-k/0001538210-22-000008 2026-05-27T10:22:51Z https://ir.neximmune.com/sec-filings/sec-filing/10-k/0001538210-23-000007 2026-05-27T10:22:51Z https://ir.neximmune.com/sec-filings/sec-filing/10-k/0001538210-24-000003 2026-05-27T10:22:51Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001193125-21-240516 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-22-000018 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-22-000024 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-22-000030 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-23-000019 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-23-000025 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-23-000033 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/10-q/0001538210-24-000008 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/3/0000950170-24-043424 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/424b5/0001193125-24-024111 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/8-k/0001193125-24-022707 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/8-k/0001193125-24-024169 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/8-k/0001193125-24-088454 2026-05-27T10:22:49Z https://ir.neximmune.com/sec-filings/sec-filing/defa14a/0001193125-24-025307 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/nt-10-k/0001193125-24-082056 2026-05-27T10:22:50Z https://ir.neximmune.com/sec-filings/sec-filing/nt-10-q/0001193125-24-139343 2026-05-27T10:22:50Z